Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

Autor:	Haddad, R.I. 1, †, Massarelli, E. 2, 3, †, Lee, J.J. 4, Lin, H.Y. 4, Hutcheson, K. 5, Lewis, J. 2, Garden, A.S. 6, Blumenschein, G.R. 2, William, W.N. 2, 7, Pharaon, R.R. 3, Tishler, R.B. 8, Glisson, B.S. 2, Pickering, C. 5, Gold, K.A. 2, 9, Johnson, F.M. 2, Rabinowits, G. 1, 10, Ginsberg, L.E. 11, Williams, M.D. 12, Myers, J. 5, Kies, M.S. 2, Papadimitrakopoulou, V. 2, *
Zdroj:	In Annals of Oncology March 2019 30(3):471-477
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu